Venomax^®

The number of National Certificate of Registration: 77.99.23.3.U.8418.10.07 dated October 17, 2007

Specification number: TU 9283-005-59230155-07

Formulation: “Dienai C”^®  (salmon roe extract (low-molecular DNA), potato starch, microcrystalline cellulose, sodium chloride, polyethylene glycol), grape seed extract..

Pharmacological group: refers to the group of food supplements-parapharmaceutics.

Toxicologic characteristics: This preparation refers to class 4 (“low-hazard substances”) according to Russian Interstate Standard 12.1.007-76. No toxic or side effects were revealed after the experimental intragastral administration to animals.

Indications: ischemic heart disease, cerebral ischemic stroke, thrombosis of arteries and veins (obliterating endarteritis, occlusive artery diseases, rethrombosis after heart surgeries and preceding thrombolytic therapy), chronic venous insufficiency, haemorrhoids, and other acute and chronic diseases associated with pathological thrombogenesis.

Administration method and dosage: orally, 1 capsule three times a day during the meal to adults and children older than 14 years. Administration duration is two weeks.

Contraindications: individual intolerance for the preparation components, pregnancy, lactation, gout, and other abnormalities in purine exchange (hyperuricemy, urine acid diathesis, urate nephrolithiasis).

Pharmaceutical form: 0.5 g capsules, 45 per package.

Storing conditions: store in a dry place away from light, out of the reach of children at temperature up to 25 oC.

Expiration date: 18 months from the date of manufacturing.

Prescription conditions: No prescription required.

Manufacturer: Siberian Center for Pharmacology and Biotechnology, closed joint-stock company (Novosibirsk, Russian Federation). Trophic ulcers.